NCT02468908View on ClinicalTrials.gov

Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Pulmonary Alveolar ProteinosisBronchiectasisCystic FibrosisAcute Respiratory Distress Syndrome
Interventions
DRUG

Molgramostim

DRUG

Placebo

Trial Locations (1)

BT9 6AD

Celerion, Belfast

Sponsors

Collaborators (1)

Celerion
All Listed Sponsors
collaborator

Celerion

INDUSTRY

lead

Savara Inc.

INDUSTRY